Team:SJTU-BioX-Shanghai/result

Contents 1 Result overview 2 Parts 3 Demonstration of new parts 3.1 Eukaryotic approach 3.1.1 Channelrhodopsin-2 (ChR2) 3.1.1.1 Structural test 3.1.1.2 Function 3.1.1.3 Real-time PCR 3.1.2 GDF5 promoter 3.1.3 MEF2-JeT promoter 3.1.4 CRE-JeT promoter 3.2 Prokaryotic approach 3.2.1 PfdhF, the hypoxia-inducible promoter 3.2.2 Oct4 4 Characterization of existing parts 4.1 RNase barnase

Result overview

After one month of brainstorming and three months of hard lab working, the SJTU-BioX-Shanghai team has successfully submitted 13 new parts, of which a large portion, such as the [http://partsregistry.org/Part:BBa_K387003 PfdhF promoter], [http://partsregistry.org/Part:BBa_K387001 MEF2-JeT promoter] and [http://partsregistry.org/Part:BBa_K387012 CRE-JeT promoter], are new parts that are demonstrated capable of working as expected. Moreover, [http://partsregistry.org/Part:BBa_I716211 RNase barnase] is an existing part in the Partsregistry, and we also have it characterized in order to provide more data.

Furthermore, we have built models which correspond to most of our experiment results, meaning they are highly simulative and thus capable of providing essential support for our design.

With the brilliant results of these main modules, our project, Synthetic-biological approaches to Osteoarthritis was proven to be highly feasible and has a great prospect to be further studied and applied. Now let us take a look at the experiment outcomes.

---

Click to jump to:

• Parts
• Demonstration of new parts
• Characterization of existing parts
• References

Parts

Go to [http://partsregistry.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2010&group=SJTU-BioX-Shanghai Partsregistry] to see our submitted parts.

Demonstration of new parts

Click to jump to:

• Channelrhodopsin-2 (ChR2)
• GDF5 promoter
• MEF2-JeT promoter
• CRE-JeT promoter
• PfdhF, the hypoxia-inducible promoter
• Oct4

Eukaryotic approach

Channelrhodopsin-2 (ChR2)

ChR2 is a widely used membrane-cross molecule in neuron-related experiments. When illuminated, it could be penetrated for many cations, such as sodium ion(Na+), calcium ion(Ca2+) and even some organic molecules which are smaller than the hole formed by ChR2. ChR2 is sensitive, especially to the light ranging in a particular bandwidth, usually between 450nm-470nm and this is the region for blue light.

Structural test

• Idea: To detect whether ChR2 is correctively expressed cross the membrane of another kind of cell, especially in mammalian somatic cells, we could transfect 293T cells with pcDNA3.1 containing the gene encoding ChR2-eYFP. If it could be expressed as the theory told us, the fusion protein--ChR2 and eYFP, will be embedded in the membrane.

• Method: We have prepared coverslips in the wells of cell culture plate before adding 293T cells. The medium is composed by DMEM, 10% FBS and 1% Penicillin/Streptomycin. We made transfection on the next day. After another 24h-culture, we picked up the coverslips out of the wells and washed them carefully by PBS. Then we treated them with 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride, which is known as DAPI dihydrochloride. This reagent could stain cell nuclear into blue, so it would be easy to observe with the help of microscope.

• Result: As we expected, we find the blue points which represent cell nuclears are surrounded by green outer covering under Laser Scanning Confocal Microscope (Leica), as shown below. After reading the paper published by Stanford on Nature Neuroscience in 2005 (Millisecond-timescale, genetically targeted optical control of neural activity), we could tell the green-labeled membrane has ChR2-eYFP embedded in. From the photo, we can be sure that ChR2 is expressed in 293T cell and more importantly, it has its correct position in the membrane, which is an essential precondition for its function. At this point, we proved the structural correctness of ChR2.

Function

• Idea: Since ChR2 could be expressed structural correctively in another kind of cell, we start to seek for the answer of whether it could work normally as in neurons. As ChR2 could initiate calcium influx, we could test its function by examining the transcription level of some certain genes which are sensitive to the change of Ca2+ concentration. Luckily, we found Zif268, a gene in Mouse Genome, and it would be up-regulated when meeting with an increase of Ca2+. On the other hand, we found discontinuous illumination is better for ChR2’s penetration for cations, while continuous illumination could cause inactivation of ChR2.

• Method: We cultured ECHO cells in 35mm-plates and the medium is composed by Ham’s/F12, 10% FBS, 1% Penicillin/Streptomycin and 0.25% Zeocin. After 24 hours, we transfected ECHO cells with pcDNA3.1, the same as above, containing ChR2-eYFP, and we wrapped the plates with foil. 24h after transfection, we carried the plates into darkroom for later experiments. We used a red light source to provide enough light for us to see and blue light pulses (around 460nm) are used to illuminate the cells. Since the blue light source is continuous, we got light pulses by pressing the switch button in a given rhythm. We tested different timescale to see the change of Zif268 transcription level. Besides the semi-quantitative measurement, we later led Realtime PCR to test quantitatively.

• Result: According to the different conditions of experimental and control groups, we could see that RNA extraction was successful. From the RT-PCR results, we know the cells transfected by ChR2-eYFP (pcDNA3.1) then illuminated for 30min showed the brightest band in Zif268 expression, followed by transfected/illuminated (20min), transfected/no illumination and no transfection/no illumination. While the bands of GAPDH showed no difference among them. The pictures are below.

Real-time PCR

• Idea: Although results from semi-quantitative PCR had primarily shown that lighting cells transfected by ChR2 could cause the ascend of the expression level of ZIF268 and ARC, which indicated that Ca²⁺ has entered cells, quantitative methods like Real-Time PCR should be more preciese and convincing. Therefore, we conducted real-time PCR for three times to render the result more precise. Besides, in order to quantify the ability of ChR2 to incorporate Ca²⁺ into cells, we refined the design of our experiment, which is shown below:

• Method: We design two sets of experiments: one is time related, in which the Ca2+ concentration is uniform (16 mM) while different groups are lighted for different time (0min, 5min, 10min, 15min and 30min) and there are two repeats for each group; the second one is Ca2+ related, in which all groups are lighted for 30 min while having different Ca2+ concentration (0mM, 4mM, 8mM, 16mM, 32mM and 64mM) and each group has three repeats. After lighting, RNA is extracted from the cells with the method mentioned before and then reverse-transcribed into cDNA by Promega’s reverse transcript kit. By adding equal quantity of cDNA into the real-time PCR system, we assume that our target gene, zif268 and ARC, if whose quantity is different in different groups, is cause by the different expression level in the cells, not by deviation from the system. The reagent for real-time PCR is SYBR@Green Reagent. After that is real-time PCR. Program for real-time PCR is shown below:

• Result: Below are the results of the amplication plot and melt curve of the three genes (GAPDH, ZIF268 and ARC) and GAPDH is considered as the reference gene.

By analyzing the data exported by StepOneR Software (supported by Applied Biosystems), we calculate out the ∆∆C_T between gene ARC and GAPDH, as well as ZIF268 and GAPDH, and the average expression level gap between different group. The result is listed below:

For ZIF268, when comparing with the value of ∆∆C_T with 0 min’s light and 0 mM Ca2+, we find that the value is dropping when lighting time or Ca2+ concentration is increasing:

When the intracellular Ca2+ concentration increases, the expression level of ZIF268 would increase as well in neuron. But the real-time PCR result is not the same to our expectation. As the intracellular condition between neuron cell and C3H10 cell has many differences, we cannot assure that all necessary factors for the expression of ZIF268 also exist in C3H10. Thus, we cannot conclude that ChR2 could function as it does in neuron cell.

While when we detect the quantity of gene ARC, there are some positive results. With the increase of lighting time or Ca2+ concentration, the quantity of ARC increases as well:

This is a powerful evidence to prove that the expression level of ARC is related to the lighting time or Ca2+ concentration. As ARC is regulated by the concentration of Ca2+, this result indicates that when lighted, ChR2 could be permeable for Ca2+, which is what we expect. Besides, from the drafts above, we find that when the concentration of Ca2+ is about 16mM, the expression level of ARC reach to the top. In addition, this experiment also proves that the expression of ARC could also be regulated by Ca2+ in C3H10, just like in neuron cell. So the expression level of ARC could act as index of the intracellular Ca2+ concentration.

• Conclusion: ChR2 could be permeable to Ca2+ when lighted and ARC could be a index of the intracellular Ca2+ concentration in C3H10, as well as in neuron cells.

---

GDF5 promoter

As can be seen from the figures (taken via fluorescent confocal microscopy), ChR2-eYFP expression is much higher in C3H10 cell line than in ECHO, suggesting that GDF5 promoter activity is much higher in mesenchymal stem cell-C3H10 cell line. Considering the transfection rate in C3H10 cell line is not as high as that in ECHO cells, the difference in activity of GDF5 promoter in these two cell lines could be much greater than what is shown in the figures. Studies have demonstrated that GDF5 gene is involved in joint formation and it is expressed in the regions of future joints during early development. Meanwhile, C3H10 cell line which is generated from mesenchymal stem cell is supposed to involve in embryonic differentiation of joint. Our result can be strong enough to show that a tissue specific promoter has been constructed successfully.

---

MEF2-JeT promoter

• Does it work as a good promoter?

• Idea: In order to test whether MEF2-Jet could function as a good promoter, we set two groups, experimental and control, to verify it. We reconstructed pcDNA3.1 by connecting MEF2-Jet with the gene encoding luciferase. So, if MEF2-Jet could work normally, the expression of luciferase will gain a huge increase than that with no promoter in its upstream.

• Method: Cultured ECHO and C3H10 cells in 24-well plate for 24h (medium for C3H10: DMEM, 10% FBS and 1% Penicillin/Streptomycin). Experimental groups were transfected with pcDNA3.1 containing MEF2-Jet-luciferase, while control groups were transfected with pGL3-Basic which contains no promoter. After another 24h, we conducted a dual-luciferase assay to measure the expression of luciferase.

• Note: We have searched related information and known the calcium concentration of the medium for C3H10 is 2mmol/L, because of the calcium ions got from DMEM and FBS.

Result: As we expected, expression level of luciferase in experimental group transfected with MEF2-Jet-luciferase largely outgrows its counterpart with pGL3-Basic. The picture below well depicts the function of MEF2-Jet as a good promoter. However, by comparing the experimental groups varying in Ionomycin concentration, we get no favorable evidence in explaining calcium ions could regulate the enhancer-promoter. In theory, after adding 5μM Ionomycin, it would have a significant intracellular increase of Ca2+, which would show a great up-regulated expression of luciferase.

---

CRE-JeT promoter

Prokaryotic approach

---

PfdhF, the hypoxia-inducible promoter

Yupeng He built and tested the hypoxia-inducible promoter, fdhF promoter (PfdfF, [http://partsregistry.org/wiki/index.php?title=Part:BBa_K387003 Part:BBa_K387003]). In this test experiment, we expected to see that, at the same OD₆₀₀, the activity of PfdhF is higher in hypoxia than in normal oxygen pressure (20%). At the beginning, both the hypoxia group and control (20% oxygen partial pressure, i.e. in air) group were incubated with 200 microlitre suspension of bacteria with the testing part (PfdhF followed by firefly luciferase). Then, we sampled both group and measured OD₆₀₀ and value of luciferase every 30 minutes (control group) or 1 hour (hypoxia). The figure was the result of this test. Our result showed that this part worked as we expected: under hypoxia, the efficiency of this promoter was much higher than that under the condition of 20% oxygen at the same OD₆₀₀. (One thing that needs to be noticed is that at 0.4 OD₆₀₀, the bacteria are in log phase and the PfdhF begins to work.)

Then we wanted to know the difference of PfdhF activity under these two conditions. So, we plotted another figure with OD₆₀₀ as x axis and the ratio of PfdhF activity under hypoxia to that under normal oxygen pressure as y axis. This curve showed that, during and after the log phase (OD₆₀₀>0.4), the activity of PfdhF is over 1.5 times more under hypoxia than under normal 20% oxygen pressure. Particularly, this ratio is over 3 when OD₆₀₀>0.5. Furthermore, in the normal 20% oxygen group, as the OD₆₀₀ increases, the oxygen supplies may be insufficient for E. coli which may lead to the increase of PfdhF activity. In this case, the activity of PfdhF under normal condition is probably overestimated. With all these data and analysis, it is evident that PfdhF is a rather good hypoxia-inducible promoter with much higher activity under hypoxia than under 20% oxygen pressure.

---

Oct4

Characterization of existing parts

RNase barnase

Due to our design containing the RNase barnase as part of our prokaryotic Supervisor, we decided to go on a journey to characterize the [http://partsregistry.org/Part:BBa_I716211 part].